Position in ALKS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$8,908,209
+$2,021,284 QoQ
Shares Held
170,004
-12.7% QoQ
Ownership
0.101%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#98
of 421 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 51%
Shared 0%
None 49%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MARTINGALE ASSET MANAGEMENT L P holds $52,615,067 across 17 Drug Manufacturers - Specialty & Generic names. ALKS ranks #2 (16.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
69,799 | $11,763,923 | |
| 2 | ALKS |
Alkermes plc.
This page
|
170,004 | $8,908,209 | |
| 3 | AMRX |
Amneal Pharmaceuticals, Inc.
|
283,033 | $4,899,301 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
7,622 | $4,129,828 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
85,564 | $3,510,690 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
|
74,348 | $3,457,925 | |
| 7 | PCRX |
Pacira BioSciences, Inc.
|
112,025 | $2,842,074 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
30,741 | $2,544,739 |
All Filings in ALKS
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,908,209 | 170,004 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $6,886,925 | 194,766 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $4,764,070 | 170,267 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,953,300 | 165,110 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,869,531 | 135,251 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $3,073,963 | 93,094 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,670,480 | 92,854 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,610,710 | 93,273 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,032,714 | 84,345 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,283,245 | 84,346 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $2,339,729 | 84,345 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $2,373,790 | 84,748 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,652,518 | 84,745 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,501,749 | 88,746 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,318,932 | 88,746 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,861,428 | 83,360 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,235,590 | 75,045 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $1,655,635 | 62,928 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $800,399 | 34,411 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,780,300 | 57,727 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||